CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01911 CR HOLDINGS

Trading 09-23 10:36:23

3.655

-0.090

-2.40%

High3.745	Low3.650	Vol15.50K
Open3.745	D1 Closing3.745	Amplitude2.54%
Mkt Cap2.09B	Tradable Cap2.09B	Total Shares573.00M
T/O57.79K	T/O Rate0.00%	Tradable Shares573.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01911","market":"HK","secType":"STK","nameCN":"CR HOLDINGS","latestPrice":3.655,"timestamp":1790130803158,"preClose":3.745,"halted":0,"volume":15500,"delay":0,"changeRate":-0.02403204272363159,"floatShares":573000000,"shares":573000000,"eps":0.19,"marketStatus":"Trading","change":-0.09,"latestTime":"09-23 10:36:23","open":3.745,"high":3.745,"low":3.65,"amount":57788,"amplitude":0.025367,"askPrice":3.675,"askSize":1100,"bidPrice":3.655,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0.154,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1790136000000},"marketStatusCode":2,"adr":0,"listingDate":1537977600000,"exchange":"SEHK","adjPreClose":3.745,"openAndCloseTimeList":[[1790127000000,1790136000000],[1790139600000,1790150400000]],"volumeRatio":0.138433,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01911/wiki","defaultTab":"wiki","newsList":[{"id":"1107498623","title":"Hong Kong Stock Market News Roundup: Insilico Medicine Secures Multi-Million-Dollar AI Collaboration Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1107498623","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107498623?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:10","pubTimestamp":1790039423,"startTime":"0","endTime":"0","summary":"Key Developments: Huanchuang Technology (06802) plans a global offering of 11.5888 million shares, with listing expected on September 30. Nazhen Technology (09856) saw its Hong Kong public offering...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06936","ARTY","BK1518","00354","03696","BK1141","LU2213484517.USD","KCAI","BK1586","VXUS","BK1526","01911","BK4585","BK1155","BK1589","AIPO","BK1151","BK4588","BK1147","AGIX","BK1161","CHAT","02595","QTOC","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669415300","title":"China Renaissance's Unit Advises AI Company on Series B+, Series C Fundraising","url":"https://stock-news.laohu8.com/highlight/detail?id=2669415300","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669415300?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:35","pubTimestamp":1789976141,"startTime":"0","endTime":"0","summary":"China Renaissance's (HKG:1911) unit CRP-Fanya Investment Consultants (Beijing) assisted Beijing SiliconFlow Technology in raising funds, a Monday bourse filing showed.Beijing SiliconFlow Technology ha","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01911","VTHR","BK1147","CHAT","AGIX","QTOC","ARTY","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122758333","title":"CR Holdings Unit Concludes Series B+ Second Tranche and Series C Funding for AI Token Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=1122758333","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122758333?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:12","pubTimestamp":1789963924,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has announced that its wholly-owned subsidiary, Huaxing Pan-Asia Investment Advisory (Beijing) Co., Ltd., acting as the exclusive financial advisor, has successfully facilitated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","ARTY","AIPO","BK1147","AGIX","QTOC","VTHR","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","LU0067412154.USD","BK1191","LU1226287529.USD","HK0000165453.HKD","01093","VXUS","LU1008478684.HKD","LU0314109678.HKD","KURE","BK1515","LU1226288253.USD","02238","BK1183","159992","BK4588","IE00BZ08YR35.GBP","LU0140636845.USD","BK1161","LU1807302812.USD","SG9999004220.SGD","BK1574","06978","LU2039709279.SGD","BK1521","LU1152091754.HKD","LU0072913022.USD","LU1226288170.HKD","IE0008369823.USD","IE00BZ08YT58.USD","BK1147","LU1960683339.HKD","IE0008368742.USD","IE00BZ08YS42.EUR","BK1119","KCAI","LNGR","LU1813983027.USD","BK4139","IBBQ","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1226287792.SGD","IE00B543WZ88.USD","06871","LU0315179316.USD","LU1993786604.SGD","LU1951186391.HKD","LU0880133367.SGD","IE00B031HY20.USD","01911","BK1539","LU1152091168.USD","LU0501845795.SGD","LU1328277881.USD","BK1144","02889","BK4585","MEDX","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133429611","title":"CR Holdings Facilitates Successful Series B Funding Round for AlphaPai, an AI Application Focused on Financial Scenarios","url":"https://stock-news.laohu8.com/highlight/detail?id=1133429611","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133429611?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:36","pubTimestamp":1789374995,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has announced that its indirect wholly-owned subsidiary, CR PanAsia Investment Advisory (Beijing) Co., Ltd., served as the exclusive financial advisor for the latest Series B...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AIQ","BK1147","01911","BK4585","159940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170094537","title":"CR Holdings Reports Zero Share Movements in August; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1170094537","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170094537?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:43","pubTimestamp":1788425034,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (“CR Holdings”, HKEX: 01911) released its Monthly Return for August 2026, confirming that no changes occurred in either authorised or issued share capital during...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857975","title":"Innovent Biologics Grants 583,731 Restricted Shares Under 2024 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857975","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664857975?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:49","pubTimestamp":1788274144,"startTime":"0","endTime":"0","summary":"Innovent Biologics grants 583,731 restricted shares under 2024 share schemeInnovent Biologics granted 59,757 share options, exercisable at HK$ 105.76 per share, with a 10-year exercise period.It also ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8nZgF0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","LU2488822045.USD","LU2097828805.USD","LU2328871848.SGD","01801","LU0244354667.USD","BK1589","LU1969619763.USD","KURE","LU0502904849.HKD","LU2097828714.EUR","LU2097828474.EUR","LU1188198961.HKD","LU2097828557.USD","LU0463099449.HKD","BK1161","HK0000165453.HKD","LU0455707207.USD","LU2242644610.SGD","BK1583","LU0326950275.SGD","BK1147","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859365","title":"Innovent Biologics Files List of Board, Board Committee Members with Disclosure Duties","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859365","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859365?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:17","pubTimestamp":1788265039,"startTime":"0","endTime":"0","summary":"Innovent Biologics files list of board, board committee members with disclosure dutiesInnovent updated its board and committee roster as of Sept. 1, 2026, naming Yu Dechao as chairman, chief executive","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL3jJnGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","01801","LU0502904849.HKD","LU0244354667.USD","BK1147","BK1583","BK1589","LU0326950275.SGD","01911","LU0463099449.HKD","LU2097828805.USD","LU2097828714.EUR","LU2097828557.USD","LU0455707207.USD","LU2097828631.EUR","LU2242644610.SGD","HK0000165453.HKD","LU2097828474.EUR","LU1188198961.HKD","BK1161","KURE","LU2488822045.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086799","title":"Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662086799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:51","pubTimestamp":1787842274,"startTime":"0","endTime":"0","summary":"Innovent Biologics files HKEX next-day disclosure return, issues 182,021 new sharesInnovent filed a next-day disclosure return on Aug. 27, 2026 for share issuances from option exercises.Issued 182,021","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL82CCyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU2328871848.SGD","01911","LU1188198961.HKD","LU1969619763.USD","KURE","LU0244354667.USD","BK1147","LU2097828805.USD","LU2097828631.EUR","LU2242644610.SGD","LU0326950275.SGD","HK0000165453.HKD","LU0455707207.USD","01801","BK1161","LU2488822045.USD","BK1589","LU0502904849.HKD","LU2097828557.USD","LU2097828474.EUR","LU0463099449.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662968777","title":"China Renaissance H1 Revenue Falls 3% as Management Fees Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2662968777","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662968777?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:23","pubTimestamp":1787822611,"startTime":"0","endTime":"0","summary":"China Renaissance H1 revenue falls 3% as management fees dropOverviewChina investment bank's H1 revenue fell 3% yr/yr as management fees declinedNet income attributable to owners dropped to RMB40.5 ml","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK1147","601375","BK4588","NOAH","BK0276","01911","BK4531","BK0201","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139707721","title":"CR Holdings Posts 37.7% Drop in Mid-Year Profit to 40.47 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1139707721","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139707721?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:21","pubTimestamp":1787822463,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has unveiled its interim results for 2026, with total revenue coming in at approximately 412 million yuan, a year-on-year decline of 3.05%. Meanwhile, the combined figure for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077221","title":"China Renaissance - Board Does not Recommend Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077221?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:11","pubTimestamp":1787821912,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662243772","title":"China Renaissance Holdings H1 Net Income Attributable RMB 40.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662243772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662243772?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:11","pubTimestamp":1787821864,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXM6BW7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662772219","title":"China Renaissance FY26 H1 Profit Attributable to Owners Falls 37.72% to RMB 40.47 Million; Revenue Drops 3% to RMB 412.18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662772219","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662772219?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:10","pubTimestamp":1787821851,"startTime":"0","endTime":"0","summary":"China Renaissance FY26 H1 profit attributable to owners falls 37.72% to RMB 40.47 million; revenue drops 3% to RMB 412.18 millionChina Renaissance posted IFRS profit attributable to owners of RMB 40.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8tDGPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732450","title":"China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732450","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732450?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:48","pubTimestamp":1787662122,"startTime":"0","endTime":"0","summary":"China's Innovent Biologics H1 revenue, profit rise on strong product salesOverviewChina biopharma firm's H1 revenue rose 44.8% yr/yr on strong product sales growthNet profit for H1 grew 50.2% yr/yr, s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","01911","688428","ABBV","LU0170899867.USD","LU0455707207.USD","RXL","LU0029864427.USD","LU2097828805.USD","LU0098860793.USD","IE00BVYPNW00.USD","IYH","01801","IXJ","VHT","BK0239","IE00BLSP4452.SGD","IE00B42XCP33.USD","SG9999015986.USD","LU0203345920.USD","LU1989772840.SGD","688331","IE00B3PB1722.GBP","JDOC","LU2097828631.EUR","TRUH","PPH","LU1551013342.USD","LU1496350171.SGD","KURE","LU0965509283.SGD","PJP","GLAM","LU0234572021.USD","IE000MB6IJN5.SGD","LU0942090050.USD","IE00BGHQF631.EUR","AGNG","01167","LU2089283258.USD","LU1732800096.USD","LU0203347892.USD","XLV","IE0002141913.USD","MEDX","LU0456855351.SGD","LU1037948541.HKD","LU2148510915.USD","FHLC","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733511","title":"Innovent Biologics H1 FY26 IFRS Profit Climbs 50.2% to RMB 1.25 Billion; Revenue Rises 44.8% to RMB 8.62 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733511","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733511?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652152,"startTime":"0","endTime":"0","summary":"Innovent Biologics H1 FY26 IFRS profit climbs 50.2% to RMB 1.25 billion; revenue rises 44.8% to RMB 8.62 billionInnovent Biologics posted IFRS profit of RMB 1.25 billion, up 50.2% year over year, on r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDLZJBKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU1969619763.USD","LU2488822045.USD","KURE","BK1589","LU0463099449.HKD","01801","LU2097828631.EUR","BK1161","BK1583","LU2097828474.EUR","LU2097828714.EUR","LU2097828557.USD","BK1147","LU2097828805.USD","LU0502904849.HKD","LU0326950275.SGD","LU0244354667.USD","LU0455707207.USD","LU2242644610.SGD","01911","LU1188198961.HKD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662202750","title":"Asian Penny Stocks: Spotlight On China Renaissance Holdings And Two More","url":"https://stock-news.laohu8.com/highlight/detail?id=2662202750","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662202750?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:02","pubTimestamp":1787608922,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of fluctuating economic indicators and investor sentiment, the Asian markets have been navigating a complex landscape, with varying performances across different indices. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat outdated moniker—continue to offer intriguing opportunities. By focusing on those with strong financials and potential for growth, investors can uncover valuable prospects within this segment of the market.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3112100-choice2-main-header/1585186903084","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112100-choice2-main-header/1585186903084"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/real-estate-management-and-development/hkg-2869/greentown-service-group-shares/news/asian-penny-stocks-spotlight-on-china-renaissance-holdings-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/real-estate-management-and-development/hkg-2869/greentown-service-group-shares/news/asian-penny-stocks-spotlight-on-china-renaissance-holdings-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999013486.USD","SG9999004360.SGD","SG9999002406.SGD","BK6509","SG9999002679.SGD","SG9999006597.SGD","LU1508157978.USD","SG9999013478.USD","01911","BK6095","SG9999016042.SGD","SG9999013460.SGD","SG9999014484.SGD","SG9999003826.SGD","F34.SI","SG9999014302.SGD","BK1147","SG9999014492.USD","SG9999000343.SGD","SGXZ58947870.SGD","SG9999002414.USD","LU2663582299.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115057484","title":"CR Holdings Schedules 27 Aug 2026 Board Meeting to Review 1H 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1115057484","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115057484?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:27","pubTimestamp":1786699667,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (CR Holdings) has announced that its board of directors will convene on 27 August 2026 to consider and approve the group’s interim results for the six months ended...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659566112","title":"China Renaissance Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659566112","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659566112?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:01","pubTimestamp":1786698091,"startTime":"0","endTime":"0","summary":"China Renaissance schedules board meeting to review interim resultsChina Renaissance set a board meeting for Aug. 27, 2026 to consider interim results for the six months ended June 30, 2026.Disclaimer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL6gNsHR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658475981","title":"Innovent Biologics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658475981","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658475981?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:05","pubTimestamp":1786352720,"startTime":"0","endTime":"0","summary":"Innovent Biologics schedules board meeting to review interim resultsInnovent Biologics set a board meeting for Aug. 25, 2026 to review interim results for the six months ended June 30, 2026.Disclaimer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLbzWXSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU0502904849.HKD","LU2097828805.USD","01801","KURE","LU1969619763.USD","LU0455707207.USD","LU2097828631.EUR","LU2328871848.SGD","LU2488822045.USD","LU2097828474.EUR","BK1161","LU2242644610.SGD","HK0000165453.HKD","LU0326950275.SGD","LU2097828557.USD","LU0244354667.USD","BK1589","LU2097828714.EUR","LU1188198961.HKD","01911","LU0463099449.HKD","BK1147"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinarenaissance.com","stockEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.1758},{"period":"3month","weight":0.1777},{"period":"6month","weight":0.0982},{"period":"1year","weight":-0.5547},{"period":"ytd","weight":-0.0932}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":-0.0354},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.0093},{"period":"1year","weight":-0.0477},{"period":"ytd","weight":-0.0212}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Renaissance Holdings Ltd is a holding company that is primarily engaged in providing investment banking and investment management services. The Company operates in four segments. Investment Banking segment provides early to late stage financial advisory and mergers and acquisitions advisory services, equity underwriting, sales, trading, brokerage, research services and structured financial services. Investment Management segment provides fund and asset management and manages its own investments in funds. China Renaissance (CR) Securities segment provides investment banking and asset management business. Others segment mainly includes wealth management business and investment and management of own funds.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.099096},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.014364},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.054298},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.054187},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.049653},{"month":6,"riseRate":0.833333,"avgChangeRate":0.099698},{"month":7,"riseRate":0.5,"avgChangeRate":0.05207},{"month":8,"riseRate":0.666667,"avgChangeRate":0.094668},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.093438},{"month":10,"riseRate":0,"avgChangeRate":-0.130048},{"month":11,"riseRate":0.285714,"avgChangeRate":0.027229},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.035994}],"exchange":"SEHK","name":"CR HOLDINGS","nameEN":"CR HOLDINGS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CR HOLDINGS,01911,CR HOLDINGS股票,CR HOLDINGS股票老虎,CR HOLDINGS股票老虎国际,CR HOLDINGS行情,CR HOLDINGS股票行情,CR HOLDINGS股价,CR HOLDINGS股市,CR HOLDINGS股票价格,CR HOLDINGS股票交易,CR HOLDINGS股票购买,CR HOLDINGS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}